Structure-activity relationships of flavonoids for vascular relaxation in porcine coronary artery

被引:100
作者
Xu, Y. C.
Leung, S. W. S.
Yeung, D. K. Y.
Hu, L. H.
Chen, G. H.
Che, C. M.
Man, R. Y. K.
机构
[1] Univ Hong Kong, Fac Med, Dept Pharmacol, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Fac Sci, Dept Chem, Hong Kong, Hong Kong, Peoples R China
[3] Univ Hong Kong, Open Lab Chem Biol, Inst Mol Technol Drug Discovery & Synth, Hong Kong, Hong Kong, Peoples R China
关键词
flavonoid; structure-activity relationship; chemical parameter; relaxation activity; porcine coronary artery;
D O I
10.1016/j.phytochem.2007.02.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Flavonoids are polyphenolic compounds that are widespread in the plant kingdom, and structure-activity relationships (SAR) for vascular relaxation effects were examined for 17 of them using porcine coronary arteries. Density functional theory was employed to calculate the chemical parameters of these compounds. The order of potency for vascular relaxation was as follows: flavones (apigenin and luteolin) >= flavonols (kaempferol and quercetin) > isoflavones (genistein and daidzein) > flavanon(ol)es (naringenin) > chalcones (phloretin) > anthocyanidins (pelargonidin) > flavan(ol)es ((+)-catechin and (-)-epicatechin). SAR analysis revealed that for good relaxation activity, the 5-OH, 7-OH, 4'-OH, C2=C3 and C4=O functionalities were essential. Comparison of rutin with quercetin, genistin with genistein, and puerarin with daidzein demonstrated that the presence of a glycosylation group greatly reduced relaxation effect. Total energy and molecular volume were also predictive of their relaxation activities. Our findings indicated that the most effective relaxing agents are apigenin, luteolin, kaempferol and genistein. These flavonoids possess the key chemical structures demonstrated in our SAR analysis. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1179 / 1188
页数:10
相关论文
共 50 条
[41]   Brassinosteroids and analogs as neuroprotectors: Synthesis and structure-activity relationships [J].
Ismaili, Jihane ;
Boisvert, Martin ;
Longpre, Fanny ;
Carange, Julie ;
Le Gall, Celine ;
Martinoli, Maria-Grazia ;
Daoust, Benoit .
STEROIDS, 2012, 77 (1-2) :91-99
[42]   Honokiol and magnolol: A review of structure-activity relationships of their derivatives [J].
Dai, Si-Yang ;
Qin, Wen-Xiu ;
Yu, Shuo ;
Li, Chang ;
Yang, Yi-Hui ;
Pei, Yue-Hu .
PHYTOCHEMISTRY, 2024, 223
[43]   Synthesis and structure-activity relationships of phaffiaol and related antioxidants [J].
Jinno, S ;
Okita, T .
CHEMICAL & PHARMACEUTICAL BULLETIN, 1998, 46 (11) :1688-1694
[44]   Further structure-activity relationships of the myxobacterial antibiotics cystothiazoles [J].
Kundim, Bangi A. ;
Qi, Jianhua ;
Fudou, Ryosuke ;
Yamanaka, Shigeru ;
Ojika, Makoto .
HETEROCYCLES, 2006, 69 (01) :231-+
[45]   Structure-activity relationship of flavonoids as potent inhibitors of carbonyl reductase 1 (CBR1) [J].
Arai, Yuki ;
Endo, Satoshi ;
Miyagi, Namiki ;
Abe, Naohito ;
Miura, Takeshi ;
Nishinaka, Toru ;
Terada, Tomoyuki ;
Oyama, Masayoshi ;
Goda, Hiroaki ;
El-Kabbani, Ossama ;
Hara, Akira ;
Matsunaga, Toshiyuki ;
Ikari, Akira .
FITOTERAPIA, 2015, 101 :51-56
[46]   Pharmaceutical Design and Structure-activity Relationships of Psoralen and Derivatives [J].
Hu, Ying-Yue ;
Wang, Yun-Can ;
Qin, Wen-Xiu ;
Yu, Shuo ;
Dai, Si-Yang ;
Pei, Yue-Hu ;
Li, Chang ;
Yang, Yi-Hui .
CURRENT PHARMACEUTICAL DESIGN, 2025,
[47]   Preparation and structure-activity relationships of novel asterriquinone derivatives [J].
Kaji, A ;
Kimura, K ;
Teranishi, M ;
Kiriyama, N ;
Nomura, M ;
Miyamoto, K .
CHEMICAL & PHARMACEUTICAL BULLETIN, 1998, 46 (08) :1325-1329
[48]   Structure-Activity Relationships of Dopamine Transporter Pharmacological Chaperones [J].
Sutton, Charles ;
Williams, Erin Q. ;
Homsi, Hoomam ;
Beerepoot, Pieter ;
Nazari, Reza ;
Han, Dong ;
Ramsey, Amy J. ;
Mash, Deborah C. ;
Olson, David E. ;
Blough, Bruce ;
Salahpour, Ali .
FRONTIERS IN CELLULAR NEUROSCIENCE, 2022, 16
[49]   Larkspur poisoning: toxicology and alkaloid structure-activity relationships [J].
Panter, KE ;
Manners, GD ;
Stegelmeier, BL ;
Lee, S ;
Gardner, DR ;
Ralphs, MH ;
Pfister, JA ;
James, LF .
BIOCHEMICAL SYSTEMATICS AND ECOLOGY, 2002, 30 (02) :113-128
[50]   Structure-activity relationships of some complex I inhibitors [J].
Miyoshi, H .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1998, 1364 (02) :236-244